GlassScriptPhysician profile
Samuel Shewan
NPI 1669875886
$22,166.59
in general payments reported to CMS, 2019-2025
10 companies · $2,582 in 2025
The $2,582 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $257 · 2022: $865 · 2023: $3,977 · 2024: $14K · 2025: $2,582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Travel and Lodging: $4,806 · Food and Beverage: $2,677 · Consulting Fee: $2,228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,333.00 |
| Travel and Lodging | $4,806.10 |
| Food and Beverage | $2,677.20 |
| Consulting Fee | $2,228.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $17,292.60 | 2023-2025 | |
| Glaxosmithkline, LLC. | $1,576.68 | 2021-2025 | Blenrep |
| Janssen Scientific Affairs, LLC | $1,456.87 | 2024 | Talvey, Carvykti |
| Pfizer INC. | $635.21 | 2022-2023 | |
| Janssen Biotech, INC. | $458.86 | 2021-2024 | Darzalex |
| Adaptive Biotechnologies Corporation | $200.61 | 2024 | Clonoseq |
| Novartis Pharmaceuticals Corporation | $149.19 | 2023-2025 | |
| Jazz Pharmaceuticals INC. | $147.01 | 2023 | |
| Celgene Corporation | $126.89 | 2025 | Abecma |
| Legend Biotech USA INC. | $122.67 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Shewan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.